Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: Need for a clinical trial?

Ursula Schröder*, Volker Dries, Jens Peter Klussmann, Claus Wittekindt, Hans Edmund Eckel

*Korrespondierende/r Autor/-in für diese Arbeit
22 Zitate (Scopus)

Abstract

We report on successful adjuvant tamoxifen therapy for a metastasizing sweat gland adenocarcinoma of the scalp in a 64-year-old woman. Before the antihormonal therapy, the patient had undergone repeated surgery for ipsilateral intraparotid, soft tissue, and lymph node metastases and had had disease-free intervals of less than 5 months. As the immunohistochemical analysis of the tumor tissue revealed a 100% nuclear reactivity to estrogen and progesterone receptors, we started empirical tamoxifen citrate therapy, which dramatically changed the course of the disease. The patient has been in complete remission for 3 years. This is the third report in the literature of substantial therapeutic benefit of antiestrogen therapy in metastasizing eccrine gland adenocarcinoma with positive hormone receptor immunohistochemistry. We suggest examining the hormone receptor expression in these neoplasms regularly. A prospective study should be commenced to assess the benefit of adjuvant antihormonal therapy in eccrine gland adenocarcinomas.

OriginalspracheEnglisch
ZeitschriftAnnals of Otology, Rhinology and Laryngology
Jahrgang113
Ausgabenummer3 I
Seiten (von - bis)242-244
Seitenumfang3
ISSN0003-4894
DOIs
PublikationsstatusVeröffentlicht - 03.2004

Fingerprint

Untersuchen Sie die Forschungsthemen von „Successful adjuvant tamoxifen therapy for estrogen receptor-positive metastasizing sweat gland adenocarcinoma: Need for a clinical trial?“. Zusammen bilden sie einen einzigartigen Fingerprint.

Zitieren